Product Description
Overall, the interventional coronary catheter market was valued at nearly $609 million in 2025. This is expected to increase over the forecast period at a CAGR of 3% to reach $751 million.
The full report suite on the global market for coronary balloon catheters includes extension guide catheters and guiding catheters.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Interventional Coronary Catheter Market Trends

The continued use of coronary catheters in angioplasty and PCI procedures will drive market expansion. Their well-established role in these interventions ensures that coronary catheters remain a fundamental component of interventional cardiology, sustaining consistent demand and strong interest from healthcare providers.
Global Interventional Coronary Catheter Market Share Insights

- Teleflex was the leading competitor in the global interventional coronary catheter market in 2025. The company currently offers the GuideLiner® extension guiding catheter and several VCD product lines.
- Medtronic gained the second-leading share in the global interventional coronary catheter market in 2025. The company produces the Launcher® and Sherpa NX™ Balanced coronary guide catheters. These two devices are designed to have a mix of support, flexibility and ease of visualization that allows them to be used in a wide variety of procedure sites.
- Boston Scientific was the third-leading competitor in the global interventional coronary catheter market in 2025. The company has shifted its focus from this market to other more profitable medical segments, but its strong sales team and brand recognition have allowed it to maintain its presence in this market.
Global Interventional Coronary Catheter Market Segmentation Summary
- Interventional Coronary Catheter Market – Further Segmented Into:
- Device Type: Extension Guide Catheter, and Guiding Catheter.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.